AstraZeneca’s Imfinzi Gets Approval In Japan For Extensive-stage Small Cell Lung Cancer

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced Friday that its Imfinzi (durvalumab) has been approved in Japan for the treatment of patients with extensive-stage small cell lung cancer or ES-SCLC. SCLC is a highly aggressive, fast-growing form of lung cancer that typically recurs and progresses rapidly, despite initial response to... To keep reading about AstraZeneca’s Imfinzi Gets Approval In Japan For Extensive-stage Small Cell Lung Cancer, Click on the link. Seoul, Korea
http://dlvr.it/Rf3bY9

Comments

Popular posts from this blog

REPORT: Airport X-Ray Finds 74 Endangered Chameleons In Man’s Suitcase

US intel chief rebukes lawmakers over 'pandemic' of leaks

New Data Suggest ExoFlo is Poised for a Quantum Leap in the Fight Against COVID-19